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ABSTRACT 
AIM: To compare reduction in intraocular pressure (IOP) and gain in visual acuity (VA) following 
phacotrabeculectomy (PT) and phacoemulsification(phaco) in Tanzanian patients with Primary 
Open Angle Glaucoma(POAG) 
SETTING: CCBRT Hospital, Dar es Salaam, Tanzania 
DESIGN: Within-person observational cohort study 
METHODS: Within each patient, one eye had PT and the other phaco. Patients were followed 
for up to 5 ½ years and IOP and VA in each eye was assessed. For a small group of patients two 
additional post-operative time points were compared. 
RESULTS: 52 patients (34 male) with a mean age of 70 years (SD 8 years), were enrolled in the 
study. For those with 250+ days follow-up, both operations resulted in lower IOPs and 
improved VA (p<0.001). The average drop in IOP was 50% (95%CI 45-55%) for PT and 41% (95% 
CI 36-46%) for phaco. Mean IOP was lower in the PT group 12.9mmHg vs 16.8mmHg (p=0.004). 
Extended follow-up in 9 patients showed a rise in IOP of 1.8mmHg for PT and 4.2mmHg for 
phaco eyes between first (mean 337 days) and second (mean 1482 days) follow-up (p=0.18).  
CONCLUSION:. In this small study in African patients phacotrabeculectomy resulted in lower 
IOPs than phacoemulsification alone but the difference between the procedures was relatively 
small. Phacoemulsification alone was effective in reducing IOP and improving VA  for several 
years in this population. Given the  relative simplicity of phacoemulsification, it is a therapeutic 
option worthy of consideration in some settings. 
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INTRODUCTION 
More than 80% of the 285 million visually impaired individuals in the world live in low and 
middle income countries, with 15% in Africa despite this continent having only 12% of the 
world’s population. 1. Cataract and glaucoma are leading causes of blindness in Africa 2,3,4. Since 
they are both age related conditions they often co-exist 5. Both have surgical solutions, but 
debate continues with respect to the optimal management strategy. Trabeculectomy surgery 
for glaucoma is known to accelerate cataract6. After trabeculectomy the risk of requiring 
cataract surgery is reported as between 20% and 52% up to 7 years postoperatively.  However, 
cataract removal after trabeculectomy surgery increases the risk of trabeculectomy failure 
which can range from 10-61% within 3 years of cataract surgery 6. Many patients in Africa are 
financially constrained and live in rural areas, rendering two operations unaffordable or 
impractical. 
We recently undertook a randomised controlled trial to evaluate the efficacy of intraoperative 
beta radiation compared with the standard 5 Fluorouracil as an adjuvant therapy in primary 
open angle glaucoma (POAG) in Tanzanian patients undergoing phacotrabeculectomy.  The 
success rate in this phacotrabeculectomy trial (PTT), as measured by a continuing IOP reduction 
(IOP<16mmHg) at one year, was over 70%.  
It has long been appreciated that cataract surgery alone lowers intraocular pressure 7, 8, 9. There 
has been increasing debate as to whether cataract surgery alone may be an option for 
management of glaucoma in some circumstances. Table 1 summarises the recent published 
literature. 
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Table 1: Summary of literature comparing IOP reduction in Phacotrabeculectomy and 
Phacoemulsification surgeries 
Ref 
No 
Title/ Author Type of study No. of eyes & 
Preoperative 
IOP 
Post-operative 
IOP  
Follow 
up 
duratio
n 
Comments 
10 Long term effects of 
phacoemulsification 
with IOL implant in 
normotensive and 
ocular hypertensive 
eyes. 
Poley B, Lindstorm R 
et al 
J Cataract Ref Surg 
2008, 34:5 Pp 735-
742 
Retrospective 
review of case 
records in 
American 
patients 
588 eyes 
 
 
31-23mmHg 
 
 
22-20mmHg 
IOP reduction 
by  
 
6.5mmHg 
(27%)  
 
4.8mmHg  
(22%) in  
pre-surgical 
 
 
 
1 year IOP reduction 
was greatest 
in eyes with 
highest pre 
surgical IOP 
and at 1 year. 
IOP sustained 
over 10 years 
11 Long term changes 
in IOP after clear 
corneal 
phacoemulsification
: Normal patients 
versus glaucoma 
suspect and 
glaucoma patients. 
Shingleton B, 
Gamell L, 
O’Donoghue M et al  
J Cataract and Ref 
Surg 1999 25:7 
 885-890 
Retrospective 
review of case 
records in 
American 
patients 
164 eyes  
 
 
 
normotensive 
IOP 16±3 
 
75 eyes 
glaucoma 
suspect 
IOP18±4 
 
71 eyes 
glaucoma group 
IOP 17±5 
 
 
 
 
 
 
14±3 
 
 
 
16±3 
 
 
 
16±4 
1 year Reduction 
statistically 
significant in 
normotensive 
and 
glaucoma 
suspect 
groups. 
12 Intraocular pressure 
reduction after 
phacoemulsification 
with intraocular lens 
implantation in 
glaucomatous and 
non-glaucomatous 
eyes: Evaluation of 
a causal relationship 
between the natural 
and open-angle 
glaucoma 
Poley B, Lindstrom 
Retrospective 
review of case 
records 
 in American 
glaucoma 
patients 
included, case 
mix of those 
on drops, had 
glaucoma 
surgery or 
both.  
124 eyes, 
Preoperative 
IOP groups 
29-23mmHg 
22-20 
19-18 
17-15 
14-5 
All eyes 
 
 
Final IOP 
change (%) 
-8.4±4.3 (34) 
-4.6±2.5 (22) 
-3.3±2.6(18) 
-1.1±2.2 (7) 
+1.9±3.6 (16) 
-2.7±4.3 (97) 
 
1-10 
years 
Higher initial 
IOP results in 
greater IOP 
reduction 
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R, Samuelson T et al 
J Cataract Refract 
Surg 2009; 35: 
1946-1955  
13 Effect of cataract 
surgery on 
intraocular pressure 
control in glaucoma 
patients 
Hayashi K, Hayashi 
H, Nakao F, Hayashi 
F 
J Cataract Refract 
Surg 2001; 27:1779-
1786 
Prospective 
included both 
Angle Closure 
and  open 
angle 
glaucoma in 
Japanese 
patients 
ACG 74 patients 
 
Preoperative 
IOP 21±4 
 
 
OAG 68 
patients 
Preoperative 
IOP 21±5 
 
Postop IOP 
reduction 
7.2±3.5 
 
 
 
Post op 
reduction  
5.3±4.8 
24 
month
s 
IOP reduction 
more and 
effect lasts 
longer  in 
ACG than 
POAG  
14 Long-term effect of 
phacoemulsification 
on  intraocular 
pressure using 
phakic fellow eye as 
control 
Chang T, Budenz D, 
Liu A, Kim W, et al 
J Cataract Refract 
Surg 2012; 38: 866-
870 
Retrospective 
review of case 
record in 
American 
patients 
Comparative 
between 
operated and 
phakic fellow 
eye 
29 eyes 
Preoperative 
IOP 16±3 
Fellow eye 
IOP 16±4 
 
Postop 
IOP 14±2 
Fellow eye 
IOP 15±3 
36 
month
s 
No significant 
IOP lowering 
effect in 
operated eye 
compared to 
phakic fellow 
eye 
 
Friedman D et al 15 did a systematic literature review to address the question of whether 
cataract surgery alone, combined cataract and glaucoma surgery or trabeculectomy surgery 
alone achieved better IOP control. They conclude: 
 There are insufficient data to determine the impact of phacoemulsification surgery on 
short term (≤ 24 hours) IOP control 
 Extra capsular cataract extraction (ECCE) surgery alone increases IOP in the short term  
 There are insufficient data to determine whether short term IOP control is better with 
combined cataract and glaucoma surgery than with cataract surgery alone 
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 There is consistent evidence that cataract extraction alone decreases the IOP of 
glaucoma patients by, on average, 2-4mmHg at 1-2 years post operatively 
 Combined phacotrabeculectomy reduces IOP by approximately 8mmHg at 1-2 years 
post operatively 
 Combined ECCE trabeculectomy lowers IOP by 6-8mmHg at 1-2 years post operatively 
 Longer term IOP control is better with combined glaucoma and cataract surgery than 
with cataract extraction alone. 
A Cochrane review undertaken by Zhang ML et al 16 found only low quality evidence that 
combined cataract and glaucoma surgery may provide a small benefit in terms of IOP control 
compared to phacoemulsification. No studies comparing cataract surgery alone with combined 
phacotrabeculectomy have been reported from Africa. 
If cataract surgery alone can reduce intraocular pressure low enough and maintain low pressure 
for a long time then this may represent a better option for elderly Tanzanian patients than 
combined cataract and glaucoma surgery. Moreover, early visual rehabilitation in such patients 
may not only encourage them to return for follow up should the need for trabeculectomy arise 
but also encourage other patients with similar conditions to attend eye clinics and undergo 
surgery. This study compares IOP and visual acuity after combined phacotrabeculectomy or 
phacoemulsification alone in eyes with both glaucoma and cataract. 
 
METHODS 
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We undertook an observational cohort study taking advantage of the PTT, to compare IOP 
reduction and visual acuity improvement after phacotrabeculectomy and phacoemulsification 
surgeries. Details of the PTT are published elsewhere 17. In summary patients with primary open 
angle glaucoma and cataract fulfilling the inclusion criteria (table 2) were recruited in the 
phacotrabeculectomy trial. For inclusion in this study both eyes had to satisfy these inclusion 
criteria. 
Table 2: Referral, Inclusion and Exclusion criteria 
 
Referral criteria Inclusion criteria Exclusion criteria 
 IOP >21mmHg 
 C/D ratio >0.8  
 Age > 40 years  
 Any form of cataract 
 Characteristic 
glaucomatous changes in 
the optic disc. The presence 
of a focal or diffuse area of 
optic disc rim loss, so that 
the  neuroretinal rim tissue 
in any quadrant is less than 
5% of the disc diameter in 
that meridian. Extensive 
loss of neuroretinal rim 
tissue with marked optic 
disc cupping giving a cup 
disc ratio greater than 0.8. 
 A measured intraocular 
pressure greater than or 
equal to 21 mmHg on at 
least one visit before the 
time of listing for surgery as 
measured by Goldmann 
applanation tonometry. 
 An open angle on gonioscopy 
 Cataract sufficient to decrease 
vision and require surgical 
intervention. 
 
 Unwillingness to 
participate in the study 
 Anterior segment 
neovascularisation 
 Past trauma to the eye or 
ocular adnexae 
 Retinal or optic nerve 
neovascularisation 
 Aphakia or pseudophakia 
 Previous ocular surgery 
 Uveitis 
 Inability/unwillingness to 
give informed consent 
 Unwillingness to accept 
randomization 
 Pregnancy or female of 
childbearing age who 
may be pregnant at the 
time of treatment ( LMP) 
 Chronic use of topical or 
systemic steroids 
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Following informed written consent, patients with bilateral POAG and cataract were enrolled in 
the PTT. Each enrolled patient underwent phacotrabeculectomy on the eye with better visual 
acuity with random allocation to receive either adjunctive 5FU or beta radiation at the time of 
surgery 17. In a number of patients enrolled in the trial, phacoemulsification with IOL implant 
alone was subsequently performed in the fellow eye. This report concerns those individuals 
who underwent phacotrabeculectomy in one eye and then phacoemulsification alone in the 
fellow eye.  The primary outcome was IOP reduction from baseline. The secondary outcome 
was visual acuity change from baseline. In the PTT, patients were reviewed on day 1, and then 
after 1, 3, 6 and 12 months. At every visit unaided and pin hole visual acuity were measured 
using a reduced logarithm of minimum angle of resolution acuity chart (log MAR) by an 
optometrist who was trained to use the chart. The tumbling E chart (log MAR) was used for 
unlettered patients. Prior to phacoemulsification surgery baseline logMAR acuities were 
recorded. If follow-up acuities were Snellen these were converted to logMAR equivalents. For 
the purposes of analysis count fingers vision at 1 metre or less was recorded as 2.0, hand 
motions as 3.0, and perception of light as 4.0. The last review with the longest period of follow-
up was taken. At a post-operative period of more than three years an attempt was made to 
review all patients again. Nine patients attended for review creating a second follow-up time 
point. Intraocular pressure was measured using a Goldmann tonometer which was calibrated 
and checked at the beginning of each clinic. For baseline IOP the median of three readings 
taken at different times of the day was taken. For follow-up of PTT the same outcome was 
used. For the phaco-only eyes a mean of two readings at separate times was used. Patients 
with increasing IOPs (>18) and/or glaucoma progression were started on appropriate anti-
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glaucoma medication. Data were recorded on a pre tested case report form and entered using 
Excel. Data were analysed using Stata version 13 ( www.stata.com). Paired t-tests were used to 
compare outcomes between eyes within individual patients. Where small numbers were 
present the non-parametric Wilcoxon matched-pairs signed-ranks test was used. P-values 
presented are 2-sided P-values.  
Ethical clearance for this observational cohort study was granted by the CCBRT hospital ethical 
committee. 
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RESULTS 
52 patients, 34 (65%) of whom were male, were enrolled in the study. In all patients the 
operation on the phacoemulsification only eye was undertaken after the phacotrabeculectomy 
eye. The phacoemulsification was undertaken a median of 125 days (first quartile 85, third 
quartile 233, range 26-902days) after the phactotrabeculectomy. Baseline characteristics of the 
study group are shown in table 3. 
Table 3: Baseline characteristics of study population 
Characteristic  N (%) 
Gender Male 34 (65%) 
Age (years) 50-59 5 (10%) 
 60-69 17 (33%) 
 70-79 27 (52%) 
 80-89 3 (6%) 
Retired  20 (38%) 
Education None 20 (38%) 
 Primary 19 (37%) 
 Secondary 5 (10%) 
 Tertiary 8 (15%) 
 
Thirteen patients were taking topical medication prior to the surgery, in all instances this 
topical therapy had been taken for less than six months in total prior to the surgery. The mean 
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preoperative spherical equivalent refractive error was -1.9 (range +2.5 to -7.25). All patients 
had gonioscopy at presentation and had wide open angles.  Mean age at phacotrabeculectomy 
surgery was 70 years (SD 8 years) and three quarters of patients were aged 65 years or more. 
Preoperative visual acuities, IOPs and CD ratios were comparable in both eyes (PT 0.68 vs P 
0.78, PT 31.8 vs P 30.4 and PT 0.81 vs P 0.79). Seven patients were on topical treatment at the 
time of last review. None were listed for further surgery. 
Final vs pre-operative IOP and VA  
Restriction to those with 250 days or more follow-up in both eyes showed strong evidence 
(p=0.004) that both operations resulted in lower IOPs with an average 16.8mmHg or 50% 
(95%CI 45-55%) drop in IOP for phacotrabeculectomy and 12.9mmHg or 41% (95% CI 36-46%) 
drop for phaco alone.  There was also evidence that both operations resulted in improved visual 
acuities in the region of 0.2 or more logMAR (P<0.001 for phacotrabeculectomy; P=0.03 for 
phacoemulsification).   
Time periods of follow-up were paired for P and PT eyes for comparison. Nine individuals had 
two time periods with matched data.. Tables 4 and 5 show the IOP and VA findings by period of 
follow-up for 61 paired time points. The overall average period of follow-up in the 
phacotrabeculectomy group was 512 days and in the phacoemulsification group 485 days. 
Apart from the very early follow-up period, the reduction in IOP was consistently greater in the 
PT group. .  
Table 4: Post-operative IOP outcomes for Phacotrabeculectomy and Phacoemulsification only 
eyes by ‘paired’ period of follow-up. 
13 
 
Mean 
ollow-up 
N Phacotrabeculectomy 
IOP (mmHg) 
Mean (SD)  
 
Phaco 
IOP 
(mmHg) 
Mean 
(SD) 
Paired ttest  
(Wilcoxon) 
Mean IOP reduction 
Phacotrabeculectomy 
Mean (range, SD) 
Mean IOP 
reduction 
Phaco mean 
(range, SD) 
Paired t test 
(Wilcoxon) 
<50 
days 
6 17.6 (SD 6.3) 15.0 (SD 
1.8) 
 p= 0.46 13.8 (4 to 36, SD 11.5) 18.0 (9 to 32, 
SD 18.2) 
 p = 0.25 
6 
months ( 
110-245 
days) 
14 14.5 (SD 6.5) 16.4 (SD 
3.3) 
 p=0.15 16.2 (-1.5to26.5, SD 7.5) 13.6 (3to20, 
SD 5.5) 
 p=0.13 
1 year 
(250-
450 
days) 
26 14.6 (SD 4.7) 15.9 (SD 
4.1) 
p=0.91 18.8 (4to48, SD 10.0) 15.1 (1to42, 
SD 8.8) 
p=0.02 
2 years 
(475-
885 
days) 
6 17 (SD 2.9) 19 (SD 
7.1) 
 p= 0.92 13.7 (6to20, SD 6.0) 9.3 (-3to18, 
SD 7.5) 
 p= 0.46 
3-5 
years 
(1140-
2022 
days) 
9 15.2 (SD 4.0) 19.8 (SD 
4.7) 
 p=0.08 13.6 (3to25, SD 6.4) 9.5 (1to17, SD 
4.6) 
 p= 0.15 
        
250-
2022 
days 
33* 15.6 (SD 4.4) 17.2 (SD 
4.8) 
p=0.06 16.8 (3to48, SD 10.0) 12.8 (-3to42, 
SD 8.4) 
p=0.009 
* The denominator is reduced here since those with more than one paired observation point were removed from the data and 
only the longest period of follow-up in each individual used for the analysis  
 
Table 5: Post-operative logMAR visual acuity outcomes for Phacotrabeculectomy (PT) and 
Phacoemulsification (P) only eyes by ‘paired’ period of follow-up. 
 
Mean follow-up N Phacotrabeculectomy logMAR change 
 Mean (range, SD) 
Phaco logMAR change 
 Mean (range, SD) 
Paired ttest (Wilcoxon) 
<50 days 6 0.08 (-0.3 to 0.4, SD 0.25) 0.07 (-1.1 to 1.7, SD 0.90) p= 0.83 
110-245 days 14 0.15 (-1to0.5, SD 0.38) 0.14 (-1.2to0.6, SD 0.43) p= 0.75 
250-450 days 26 0.28 (-0.2to1.5, SD 0.34) 0.23 (-1.6to1.7, SD 0.73) p= 0.37  
475-885 days 6 0.32 (-0.3to1.5, SD 0.61) 0.21 (-0.1to0.50, SD 0.21) p=0.35 
1140-2022 days 9 0.13 (-0.8to0.6, SD 0.40) -0.07 (-3.1to1.4, SD 1.28) p=0.68 
     
250-2022 days 33* 0.28 (-0.8to1.5, SD 0.43) 0.04 (-3.1to1.7, SD 0.87) p=0.06 
* The denominator is reduced here since those with more than one paired observation point were removed from the data and 
only the longest period of follow-up in each individual used for the analysis  
Change over time between follow-up points 
In 9 individuals with two paired time points. The rise in IOP between first (mean 337 days post-
operatively) and second (mean 1482 days postoperatively) follow-up was 1.8mmHg in the 
phacotrabeculectomy eyes and 4.2mmHg in the phaco eyes (p=0.18). One individual had 
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acuities of 0.5 logMAR in each eye at the first follow-up and acuities of 1.5 logMAR in the 
phacotrabeculectomy eye and perception of light in the phaco eye at second follow-up. The 
remainder had a mean acuity of 0.03 logMAR units worse in the phacotrabeculectomy eyes and 
0.25 logMAR units worse in the phaco eyes at second follow-up. All phaco eyes had higher IOPs 
at later follow-up whilst 4 (44%) of the phacotrabeculectomy eyes had further lowering of the 
intraocular pressure. All phaco eyes had worse acuities at later follow-up whilst 4 (44%) of the 
phaco-trabeculectomy eyes had further improved acuity.  
 
DISCUSSION 
This is the first study to report the effect of phacoemulsification on IOP control in African 
patients with POAG. We observed a much larger IOP reduction in Tanzanian patients for both 
procedures when compared to non-African populations reported elsewhere 10-14.  The reported 
IOP reduction after phacoemulsification in POAG patients does not exceed 34% in other 
populations 12 while we report a 41% reduction (95%  CI 36-46%). Proposed reasons for IOP 
reduction following cataract surgery include opening of the angle.  Studies have shown that the 
anterior chamber angle opens in all eyes after cataract extraction 18, 19, 20. Tia M et al further 
noted in their study 19 that the angle widening depends on the patient’s age with more angle 
widening in patients older than 60 years. They argue that this could be because of thicker 
lenses in older patients. It has been observed that after phacoemulsification the anterior 
chamber angle can widen and deepen by up to 50% 20. The mean age of patients in our study 
was 70 years and more than 75% were at least 65 years old. Furthermore, cataract surgery 
results in chronic inflammation in the eye with flare in the anterior chamber persisting for up to 
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6 months following the procedure. Ciliary body or low grade trabecular meshwork 
inflammation (as in selective laser trabeculoplasty) could also result in a lowering of IOP 21. A 
South African study by Cook et al in 1998 demonstrated that there is an exaggerated 
inflammatory response in African patients post cataract surgery which can persist up to 6 
months post operatively 22.  Bhallil S et  al 23 suggest that possible mechanisms of IOP reduction 
after phacoemulsification may include: 1) Free radicals produced during surgery  may act as 
inflammatory mediators; ciliary body irritation by the inflammatory mediators could result in 
hypo secretion of aqueous humour 2) Trabecular meshwork irrigation during surgery may 
decrease outflow resistance 3) Increase in surgically induced production of endogenous 
prostaglandins may augment uveoscleral outflow and 4) phaco ultrasound stimulates 
production of interleukins 1α by trabecular meshwork thus increasing outflow facility and 
decreasing IOP.   
This study addresses an important question for African populations in which most patients 
present very late when one eye is nearly lost from glaucoma and the other eye has advanced 
disease 24.  In this context, surgery is often the first line of treatment. Trabeculectomy only in 
African patients with co-existing cataract has an important drawback: pre-existing cataract 
tends to worsen, reducing vision so that within a short period of time further surgery is 
required to improve vision. This involves additional cost and inconvenience.  
Combining the two operations in the form of phacotrabeculectomy is appealing as it addresses 
both the conditions. However this is not a simple procedure. It requires surgeons trained in this 
procedure of whom there are relatively few in Africa. Moreover, phacotrabeculectomy has 
16 
 
potential complications which may require further surgical interventions like bleb revision, bleb 
needling, or sub-Tenon’s 5Fluorouracil (5FU) injections. In addition, visual gain may be 
compromised by an initial exaggerated inflammatory response, hypotony and refractive errors 
25,26. Frequent follow up is therefore desirable, but this may require the patient to remain close 
to the hospital, which may not be possible. In these circumstances, phacoemulsification surgery 
alone may be a better option because: 
 It is technically easier 
 Visual rehabilitation is faster 
 There are fewer complications compared to the combined procedure 
 A majority of the patients are elderly and their main concern for the remaining period of 
their lives is better vision for limited mobility around their surroundings.  
Phacoemulsification satisfies this requirement immediately postoperatively.  
 Patients do not need close and frequent follow up in comparison to trabeculectomy 
alone or combined with phacoemulsification.  
The question is whether cataract surgery alone can reduce intraocular pressure enough to 
slow the glaucomatous process and for how long? Our study indicates that although the IOP 
reduction following phacoemulsification may not be as marked as that achieved with 
phacotrabeculectomy, the effect did last for several years post-operatively.  
A strength of this study is its within-individual design, which removes between individual 
variation as a source of uncertainty. However, the allocation of eyes within an individual to 
a particular procedure and the order of the procedures were not randomised. The eye with 
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the better acuity was selected for phacotrabeculectomy which was performed before 
phacoemulsification. Nevertheless, there were not major pre-operative differences 
between the eyes. The sample size of our study was small, particularly for long-term follow-
up, and there may be important differences that this study was not powered to detect.   
 
CONCLUSION 
In this small study in African patients phacotrabeculectomy resulted in lower IOPs than 
phacoemulsification alone but the difference between the procedures was relatively small. 
Phacoemulsification alone was effective in reducing IOP and improving VA  for several years in 
this population. Given the  relative simplicity of phacoemulsification, it is a therapeutic option 
worthy of consideration in some settings. 
The challenges of therapy for this blinding disease in an African context are enormous. We 
are currently undertaking qualitative work to investigate patient attitudes to the disease 
and its therapy to further inform therapeutic strategies.  
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